Allosterically targeting EGFR drug-resistance gatekeeper mutations.

ABSTRACT:

SUBMITTER: Spellmon N 

PROVIDER: S-EPMC5542946 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature